Prioritizing MMP8 as an exploratory therapeutic candidate in Parkinson's disease through proteome-wide Mendelian randomization and computational multi-omics integration.
The 32 proteins with nominal MR associations represent candidates for follow-up investigation and should be interpreted as exploratory because a verified proteome-wide FDR correction could not be established.